(Q36463101)

14 August 2017

1 reference

title

Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer (English)

1 reference

14 August 2017

1 reference

1 reference

7

Udo Jonas

1 reference

14 August 2017

Stefan Machtens

1

1 reference

14 August 2017

Rolf Baumann

2

1 reference

14 August 2017

Jörn Hagemann

3

1 reference

14 August 2017

Antje Warszawski

4

1 reference

14 August 2017

Andreas Meyer

5

1 reference

14 August 2017

Johann H Karstens

6

1 reference

14 August 2017

1 August 2006

1 reference

14 August 2017

World Journal of Urology

1 reference

14 August 2017

24

1 reference

14 August 2017

289-295

1 reference

14 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-006-0083-1

14 August 2017

0 references

cites work

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Potency after permanent prostate brachytherapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Erectile function after prostate brachytherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

A dose-response study for I-125 prostate implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Palladium-103 brachytherapy for prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Short-term morbidity from CT-planned transperineal I-125 prostate implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

High dose combination radiotherapy for the treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Temporal resolution of urinary morbidity following prostate brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-006-0083-1

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

21 January 2018

1 reference

12 December 2020

12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer

1 reference

12 December 2020

Complications following permanent prostate brachytherapy

1 reference

12 December 2020

Rectal dosimetric analysis following prostate brachytherapy

1 reference

12 December 2020

Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry: implications for dose specification and prescription

1 reference

12 December 2020

Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis

1 reference

12 December 2020

The treatment of carcinoma of the prostate by interstitial radiation with radioactive gold (Au198); a follow-up report

1 reference

12 December 2020

Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer

1 reference

12 December 2020

Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy

1 reference

12 December 2020

[Recommendations for treatment with permanent, interstitial brachytherapy alone in locally limited prostate cancer]

1 reference

12 December 2020

Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration

1 reference

12 December 2020

The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma

1 reference

12 December 2020

The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis

1 reference

12 December 2020

A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States

1 reference

12 December 2020

Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy

1 reference

12 December 2020

Importance of post-implant dosimetry in permanent prostate brachytherapy

1 reference

12 December 2020

Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography

1 reference

12 December 2020

Retropubic Implantation of Iodine 125 in the Treatment of Prostatic Cancer

1 reference

12 December 2020

Prostate brachytherapy: treatment strategies

1 reference

12 December 2020

Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer

1 reference

12 December 2020

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

12 December 2020

Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer

1 reference

12 December 2020

Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy

1 reference

12 December 2020

Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice

1 reference

12 December 2020

ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer.

1 reference

12 December 2020

American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy. The clinical research committee of the American Brachytherapy Society

1 reference

12 December 2020

Analysis of biopsy findings and implant quality following ultrasonically-guided 125I implantation for localised prostatic carcinoma

1 reference

12 December 2020

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

12 December 2020

Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer

1 reference

12 December 2020

Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation

1 reference

12 December 2020

Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.

1 reference

12 December 2020

Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy

1 reference

12 December 2020

Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: a matched subset analysis

1 reference

12 December 2020

Detailed preliminary analysis of 125iodine implantation for localized prostate cancer using percutaneous approach

1 reference

12 December 2020

10.1007/S00345-006-0083-1

Identifiers

DOI

1 reference

14 August 2017

1 reference